Table 4.
Comparison between stricture and non-stricture groups
| p value | Non-UES group (114 patients) |
UES group (21 patients) |
Variable |
|---|---|---|---|
| 0.99 | 66.6 (9.6) | 69.9 (10) | Age (years), mean (SD) |
| 0.9 | 87 (76.3) | 16 (76.2) | Male gender, n (%) |
| 0.2 | 26.7 (4.6) | 28.2 (6.5) | BMI (kg/m2), mean (SD) |
| 0.1 | 1.1 (0.4) | 1.09 (0.18) | Preoperative serum creatinine (mg ∕dl), mean (SD) |
| 0.88 | 15 (13.1) | 3 (14.2) | Diabetes mellitus, n (%) |
| 0.34 | 45 (39.4) | 6 (28.5) | Cardiovascular disease, n (%) |
| 0.05 | 41(35.9) | 3 (14.2) | Smoking history, n (%) |
| 0.36 | 50 (43.8) | 7 (33.3) | ASA score ≥ 3, n (%) |
| 0.06 | 37 (15.7) | 9 (30) | Preoperative hydronephrosis/renal units, n (%) |
| 0.01 | 5 (4.3) | 4 (19) | Preoperative chemotherapy, n (%) |
| 0.12 | 6 (5.2) | 3 (14.2) | History of pelvic radiotherapy, n (%) |
| 0.55 | 16 (14) | 4 (19) | History of abdominal surgery, n (%) |
| 0.69 |
87 (76.3) 24 (21) 3 (2.6) |
17 (81) 3 (14.2) 1 (4.7) |
Diversion technique, n (%) Ileal conduit Orthotopic neobladder Continent cutaneous |
| 0.3 | 26 (22.8) | 7 (33.3) | 90 day-Clavian grade ≥ III, n (%) |
| 0.61 | 9 (7.9) | 1 (4.7) | Urinary leakage, n (%) |
| 0.89 | 56 (49.1) | 10 (47.6) | Local advanced dis., n (%) |
| 0.27 | 30 (26.3) | 8 (38.1) | Node positive dis., n (%) |